Field of interest: Life Sciences & Medicine
-
Core Research Projects
GENERIC: Reconstructing gene regulatory networks with neural relational inference
Learn moreDiscovering structures and dynamics of gene regulatory networks (GRNs) based on large-scale high throughput data is a fundamental research challenge in systems biology. The reconstruction of accurate GRNs from data is challenging because of not only the large number of parameters and components involved, but also their possible mutual interactions. The inferred network models can…
-
Core Research Projects
Active phenomena across scales in biological systems (ACTIVE)
Learn moreNew perspectives on the multiscale organisation of life by developing new concepts of active matter across biological scales.
-
Research Projects Pages
PDE6D/KRAS inhibitor development for cancer treatment (inhibitPDE-RASv2)
Learn more -
Core Research Projects
PDE6D/KRAS inhibitor development for cancer treatment (inhibitPDE-RASv2)
Learn more -
Research Projects Pages
MEL-PLEX – Exploiting MELanoma disease comPLEXity to address European research training needs intranslational cancer systems biology and cancer systems medicine
Learn more -
Core Research Projects
Exploiting MELanoma disease comPLEXity to address European research training needs intranslational cancer systems biology and cancer systems medicine (MEL-PLEX)
Learn more -
Research Projects Pages
Personal functional profiling for drug discovery in melanoma and colorectal cancer (MelCol-PFP)
Learn more -
Core Research Projects
Personal functional profiling for drug discovery in melanoma and colorectal cancer (MelCol-PFP)
Learn more -
Research Projects Pages
Colorectal Cancer Collection – Colorectal cancer sample collection
Learn moreSince 2010, the Molecular Disease Mechanisms Group at the University of Luxembourg has established an ongoing collection of 160 high quality tumor tissue samples from colorectal cancer patients.
-
Core Research Projects
Colorectal Cancer Collection – Colorectal cancer sample collection
Learn moreThe Molecular Disease Mechanisms Group at UL/DLSM has established an ongoing collection of 160 high quality tumor tissue samples from CRC patients